Recent Activity

Loading...

INDV

Indivior PLC · NASDAQ

Performance

-5.04%

1W

-12.48%

1M

-3.36%

3M

+4.17%

6M

+11.13%

YTD

-8.39%

1Y

Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Investment Analysis Report: INDV

Overview

In this investment analysis report, we will delve into a comprehensive analysis of INDV, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...

See more ...

Technical Analysis of INDV 2024-05-10

Overview:

In analyzing the technical indicators for INDV over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and recommendations for your investm...

See more ...

Recent News & Updates